AIDS oncology

Infect Dis Clin North Am. 2000 Dec;14(4):945-65, vii. doi: 10.1016/s0891-5520(05)70141-0.

Abstract

Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, and squamous cell carcinoma are among the malignancies seen with increased frequency in patients infected with HIV. The outlook for patients with these malignancies has improved significantly with the utilization of highly active antiretroviral therapy (HAART) and more aggressive cytotoxic therapies. Novel biologic therapies with lesser side effects are currently being evaluated. This article reviews the current knowledge about HIV malignancies, their epidemiology, pathogenesis, clinical manifestations, and treatment.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell* / epidemiology
  • Carcinoma, Squamous Cell* / physiopathology
  • Carcinoma, Squamous Cell* / therapy
  • Female
  • HIV Infections / complications*
  • Hodgkin Disease / epidemiology
  • Hodgkin Disease / physiopathology
  • Hodgkin Disease / therapy
  • Humans
  • Lymphoma, AIDS-Related* / epidemiology
  • Lymphoma, AIDS-Related* / physiopathology
  • Lymphoma, AIDS-Related* / therapy
  • Male
  • Sarcoma, Kaposi* / epidemiology
  • Sarcoma, Kaposi* / physiopathology
  • Sarcoma, Kaposi* / therapy

Substances

  • Antineoplastic Agents